Gronski P, Bodenbender L, Kanzy E J, Loos M, Seiler F R
Immunobiology. 1985 May;169(4):346-61. doi: 10.1016/S0171-2985(85)80016-4.
Classical pathway (CP)-triggered reactions of complement-modulated immune complex (IC) aggregation (tetanus toxoid/human anti-tetanus toxoid-IgG; ICs of equivalence) were investigated turbidimetrically during the early stages of reaction. Monospecific Fab'- or Fab-fragments (rabbit) directed against certain complement components were used to block the complement function in normal human serum (NHS). Additionally, parts of the reactions were studied using purified complement components. C1q in serum generated by the addition of EDTA as well as purified C1q were found to increase the IC aggregation. In contrast to C1q, macromolecular C1 is able to inhibit IC aggregation, whereas additional participation of C-1 INH reversed this process. The cooperation of the remaining CP proteins (C4, C2, C4bp, and I) reconstituted the inhibition capacity of the complement. Whereas C3 supported significantly inhibition, a significant influence of other effector pathway (EP) components (C5-C9) was not detectable turbidimetrically.
在反应早期,通过比浊法研究了经典途径(CP)触发的补体调节免疫复合物(IC)聚集反应(破伤风类毒素/人抗破伤风类毒素-IgG;等价IC)。使用针对某些补体成分的单特异性Fab'-或Fab-片段(兔)来阻断正常人血清(NHS)中的补体功能。此外,使用纯化的补体成分研究了部分反应。发现通过添加EDTA在血清中产生的C1q以及纯化的C1q可增加IC聚集。与C1q相反,大分子C1能够抑制IC聚集,而C-1 INH的额外参与则逆转了这一过程。其余CP蛋白(C4、C2、C4bp和I)的协同作用恢复了补体的抑制能力。虽然C3显著支持抑制作用,但通过比浊法未检测到其他效应途径(EP)成分(C5-C9)的显著影响。